All are true about Hemolytic uremic syndrome except?
## Core Concept
Hemolytic uremic syndrome (HUS) is a complex condition characterized by **microangiopathic hemolytic anemia**, **acute kidney failure**, and **low platelet count (thrombocytopenia)**. It often presents as a triad of microangiopathic hemolytic anemia, thrombocytopenia, and acute kidney injury. The most common cause of HUS is infection with **Shiga toxin-producing Escherichia coli (E. coli)**, particularly the O157:H7 serotype.
## Why the Correct Answer is Right
The correct answer is related to the specifics of HUS pathophysiology and clinical presentation. HUS is primarily associated with **Shiga toxin-producing E. coli** infections, leading to **endothelial damage** and activation of the coagulation cascade within small blood vessels. This results in the formation of **microthrombi**, consumption of platelets, and mechanical damage to red blood cells, leading to the characteristic laboratory findings.
## Why Each Wrong Option is Incorrect
- **Option A:** Typically, HUS is indeed associated with **thrombocytopenia** due to platelet consumption in the formation of microthrombi. Therefore, stating that thrombocytopenia is a feature of HUS would be correct, making this option incorrect as an "except" choice.
- **Option B:** HUS is characterized by **schistocytes** (fragmented red blood cells) on a blood smear due to the mechanical shearing of red cells as they pass through small vessels partially occluded by microthrombi. This option would also be a true statement about HUS.
- **Option C:** **Elevated serum creatinine** is a marker of **acute kidney injury**, which is a hallmark of HUS. The renal involvement in HUS can range from mild to severe and is a critical component of the syndrome.
- **Option D:** This option would need to specify why it's incorrect in relation to HUS. If an option suggests that **HUS is primarily caused by a complement pathway dysregulation**, this would be misleading as the primary cause. While **atypical HUS (aHUS)** is indeed related to dysregulation of the complement pathway, stating this as a characteristic of HUS in general might be misleading without specifying "atypical" HUS.
## Clinical Pearl / High-Yield Fact
A key clinical pearl is that **the classic triad of HUS includes microangiopathic hemolytic anemia, thrombocytopenia, and acute kidney injury**. Additionally, **Shiga toxin-producing E. coli (STEC) HUS** is the most common form of HUS and often follows a diarrheal illness caused by E. coli O157:H7. Atypical HUS (aHUS) represents a distinct subgroup with a different pathophysiology involving complement dysregulation.
## Correct Answer: D.